FindTrial
Sign In

Study to Evaluate the Benefits of Sea Buckthorn Juice Along with Usual Treatment in Patients with Type 2 Diabetes Mellitus

Evaluation of Sea Buckthorn Juice Supplementation as an Adjunct to Standard of Care in Patients with Type 2 Diabetes Mellitus: A Prospective, Open-label, Parallel-group Comparative Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109775
Enrollment
50
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Sea Buckthorn Juice Supplementation: Participants in the intervention arm will receive Sea Buckthorn juice along with standard of care for Type 2 Diabetes Mellitus. The juice will be ad

Sponsors

Wellwith India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or female aged between 30 to 65 years HbA1c between 7 percent and 10 percent Diagnosed with T2DM for at least 6 months Able to provide informed consent

Exclusion criteria

Exclusion criteria: Type 1 diabetes or acute complications including DKA and HHS Uncontrolled hypertension more than or equal to 160 and 100 mmHg Recent cardiovascular events in last 6 months Severe liver or kidney dysfunction On anticoagulants Active infection or malignancy or autoimmune disease Pregnant or lactating women Allergy to Sea Buckthorn

Design outcomes

Primary

MeasureTime frame
Mean change in HbA1c levels from baseline to Week 12Timepoint: 12 weeks—

Secondary

MeasureTime frame
Mean change in fasting blood glucose (FBG)Timepoint: 12 weeks;Change in body weight, BMI, waist and hip circumferenceTimepoint: 12 weeks;Change in lipid profile (Total cholesterol, LDL-C, HDL-C, triglycerides)Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactPunit Srivastava

Mediception Science Pvt Ltd

punit@mediception.com9899056449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026